The stroke centers at Florida-based Memorial Regional Hospital and Memorial Hospital West, both part of Memorial Healthcare System, have recently achieved recognition from The Joint Commission and the American Heart Association/American Stroke Association, according to an announcement.
Memorial Regional Hospital has earned The Joint Commission’s Gold Seal of Approval for Comprehensive Stroke Centers. In addition, it was awarded the Get With The Guidelines Stroke Gold Plus and Target Stroke Elite Plus Quality Achievement Awards by the American Heart Association/American Stroke Association.
Memorial Hospital West also achieved the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite Plus.
“By achieving this advanced certification, Memorial Regional Hospital has thoroughly demonstrated the greatest level of commitment to the care of its patients with a complex stroke condition,” says Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, The Joint Commission, in the release, from Memorial Healthcare System.
“Certification is a voluntary process and The Joint Commission commends the hospital for successfully undertaking this challenge to elevate the standard of its care for the community it serves,” he adds.
To be eligible for The Joint Commission honor, hospitals must demonstrate compliance with stroke-related standards as a Primary Stroke Center and meet additional requirements, including those related to advanced imaging capabilities, 24/7 availability of specialized treatments, and providing staff with the unique education and competencies to care for complex stroke patients, the release explains.
Hospitals must achieve 85% or higher adherence to all Get With The Guidelines-Stroke achievement indicators for two or more consecutive 12-month periods and achieve 75% or higher compliance with five of eight Get With The Guidelines-Stroke Quality measures to receive the Gold Plus Quality Achievement Award.
To qualify for the Target: Stroke Honor Roll Elite Plus, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the FDA to treat ischemic stroke, the release continues.
[Source(s): Memorial Healthcare System, PRWeb]
